%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Scott Mitchell, John P. Williams, Harsimrandeep Bhatti, Toufic Kachaamy, Jeffrey Weber, Glen J. Weiss
A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 10 0 R/Annots 11 0 R/Contents 12 0 R/TrimBox[0 0 612 792]>>
endobj
11 0 obj
[13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R]
endobj
13 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188628.ref001)>>
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188628.ref001)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188628.ref002)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188628.ref003)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188628.ref004)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188628.ref005)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188628.ref006)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188628.ref007)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188628.ref010)>>
endobj
22 0 obj
<>/Border[0 0 0]/A 23 0 R>>
endobj
23 0 obj
<>
endobj
12 0 obj
[24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R]
endobj
24 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 619.9101 m
199.9998 619.9101 l
199.9998 620.4101 l
575.9997 620.4101 l
f*
0.83 0.64 0.02 0 k
491.9244 537.5055 m
496.6866 537.5055 l
h
f*
518.9669 524.5228 m
523.7291 524.5228 l
h
f*
525.9402 524.5228 m
530.7024 524.5228 l
h
f*
529.2283 485.5181 m
533.9906 485.5181 l
h
f*
376.8945 459.5528 m
381.6567 459.5528 l
h
f*
315.6661 446.5134 m
320.4283 446.5134 l
h
f*
275.2441 381.5433 m
280.0063 381.5433 l
h
f*
291.2315 342.5386 m
295.9937 342.5386 l
h
f*
301.1528 342.5386 m
310.6772 342.5386 l
h
f*
0 g
1 j
1 J
11.4998 0 0 11.4998 200.0125 706.3937 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusions)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 689.3858 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(In)Tj
1.0443 0 Td
(this)Tj
1.7604 0 Td
(small)Tj
2.5244 0 Td
(study,)Tj
2.8644 0 Td
(PEG)Tj
2.3274 0 Td
(placement)Tj
4.7801 0 Td
(had)Tj
1.8679 0 Td
(inferior)Tj
3.2285 0 Td
(OS)Tj
1.665 0 Td
(outcome)Tj
4.0162 0 Td
(for)Tj
1.3785 0 Td
(GE)Tj
1.659 0 Td
(esophageal)Tj
5.3232 0 Td
(carcinoma,)Tj
-34.4393 -1.474 Td
(no)Tj
1.3188 0 Td
(improvement)Tj
5.9378 0 Td
(in)Tj
0.9847 0 Td
(OS)Tj
1.665 0 Td
(for)Tj
1.3725 0 Td
(other)Tj
2.4766 0 Td
(evaluated)Tj
4.4996 0 Td
(groups,)Tj
3.5209 0 Td
(and)Tj
1.8619 0 Td
(did)Tj
1.5337 0 Td
(not)Tj
1.5934 0 Td
(reduce)Tj
3.2404 0 Td
(weight)Tj
3.0793 0 Td
(loss)Tj
1.9753 0 Td
(between)Tj
-35.0599 -1.468 Td
(baseline)Tj
3.8909 0 Td
(and)Tj
1.8619 0 Td
(12-week)Tj
3.9565 0 Td
(follow-up.)Tj
4.4459 0 Td
(Unless)Tj
3.2405 0 Td
(there)Tj
2.4765 0 Td
(is)Tj
0.931 0 Td
(prospective)Tj
5.2754 0 Td
(randomized)Tj
5.3828 0 Td
(trial)Tj
1.8082 0 Td
(that)Tj
1.8679 0 Td
(can)Tj
1.8142 0 Td
(show)Tj
-36.9517 -1.474 Td
(superiority)Tj
4.7741 0 Td
(of)Tj
1.0443 0 Td
(PEG)Tj
2.3274 0 Td
(placement)Tj
4.7801 0 Td
(in)Tj
0.9847 0 Td
(this)Tj
1.7604 0 Td
(population,)Tj
5.0427 0 Td
(PEG)Tj
2.3274 0 Td
(placement)Tj
4.7801 0 Td
(in)Tj
0.9846 0 Td
(this)Tj
1.7605 0 Td
(group)Tj
2.7391 0 Td
(cannot)Tj
3.1927 0 Td
(be)Tj
-36.4981 -1.474 Td
(endorsed.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 568.6299 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 551.622 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Gastroesophageal)Tj
7.2453 0 Td
(\(GE\))Tj
2.1826 0 Td
(cancers)Tj
3.2088 0 Td
(are)Tj
1.4457 0 Td
(known)Tj
3.0047 0 Td
(to)Tj
1.0261 0 Td
(commonly)Tj
4.5468 0 Td
(produce)Tj
3.5206 0 Td
(a)Tj
0.6519 0 Td
(variety)Tj
2.9254 0 Td
(of)Tj
1.0148 0 Td
(GE-related)Tj
-30.7727 -1.3039 Td
(symptoms,)Tj
4.5807 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(dysphagia)Tj
4.2066 0 Td
(and)Tj
1.7291 0 Td
(cachexia)Tj
3.6227 0 Td
(that)Tj
1.7745 0 Td
(can)Tj
1.627 0 Td
(lead)Tj
1.8539 0 Td
(to)Tj
1.0204 0 Td
(malnutrition)Tj
5.3575 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5987 0 Td
(The)Tj
1.7858 0 Td
(prevalence)Tj
4.4844 0 Td
(of)Tj
-36.7197 -1.2982 Td
(malnutrition)Tj
5.3517 0 Td
(incidents)Tj
3.8891 0 Td
(in)Tj
1.0318 0 Td
(these)Tj
2.2564 0 Td
(populations)Tj
4.9493 0 Td
(can)Tj
1.627 0 Td
(range)Tj
2.4605 0 Td
(from)Tj
2.2053 0 Td
(4085%)Tj
3.4016 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3675 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
2.3017 0 Td
(Control-)Tj
-33.8567 -1.2983 Td
(ling)Tj
1.7461 0 Td
(malnutrition)Tj
5.3518 0 Td
(is)Tj
0.8503 0 Td
(a)Tj
0.652 0 Td
(major)Tj
2.6079 0 Td
(concern)Tj
3.4696 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(treatment)Tj
4.1329 0 Td
(of)Tj
1.0147 0 Td
(patients)Tj
3.3676 0 Td
(undergoing)Tj
4.8755 0 Td
(anti-neoplastic)Tj
-30.5742 -1.2983 Td
(therapy.)Tj
3.4695 0 Td
(Cancer-associated)Tj
7.4721 0 Td
(malnutrition)Tj
5.3575 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(shown)Tj
2.846 0 Td
(to)Tj
1.0261 0 Td
(lower)Tj
2.4548 0 Td
(a)Tj
0.652 0 Td
(patient's)Tj
3.5829 0 Td
(response)Tj
3.7361 0 Td
(to)Tj
1.0261 0 Td
(anti-)Tj
-35.2854 -1.3039 Td
(neoplastic)Tj
4.2462 0 Td
(therapies,)Tj
4.0705 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8199 0 Td
(as,)Tj
1.2359 0 Td
(amplify)Tj
3.2485 0 Td
(the)Tj
1.4683 0 Td
(risk)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(chemotherapy-induced)Tj
9.547 0 Td
(toxicity)Tj
3.1975 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
1.6044 0 Td
(In)Tj
1.1055 0 Td
(addi-)Tj
-35.2911 -1.2982 Td
(tion,)Tj
2.0636 0 Td
(malnutrition)Tj
5.3574 0 Td
(is)Tj
0.8447 0 Td
(one)Tj
1.7008 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(main)Tj
2.2904 0 Td
(contributors)Tj
5.2101 0 Td
(towards)Tj
3.4015 0 Td
(a)Tj
0.652 0 Td
(decline)Tj
3.0841 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(patient's)Tj
3.583 0 Td
(nutritional)Tj
-32.3601 -1.2983 Td
(status)Tj
2.5001 0 Td
(and)Tj
1.7291 0 Td
(their)Tj
2.109 0 Td
(overall)Tj
2.9026 0 Td
(quality)Tj
2.9537 0 Td
(of)Tj
1.0148 0 Td
(life)Tj
1.4457 0 Td
(\(QoL\))Tj
2.6929 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.5987 0 Td
(Malnutrition)Tj
5.4255 0 Td
(has)Tj
1.5477 0 Td
(also)Tj
1.7631 0 Td
(been)Tj
2.126 0 Td
(shown)Tj
2.846 0 Td
(to)Tj
1.0261 0 Td
(lead)Tj
1.8538 0 Td
(to)Tj
1.0262 0 Td
(an)Tj
-36.561 -1.3039 Td
(increase)Tj
3.4695 0 Td
(in)Tj
1.0375 0 Td
(health)Tj
2.6759 0 Td
(care)Tj
1.8709 0 Td
(costs)Tj
2.1713 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.6044 0 Td
(Thus,)Tj
2.4718 0 Td
(mitigating)Tj
4.3483 0 Td
(and)Tj
1.7348 0 Td
(alleviating)Tj
4.3029 0 Td
(malnutrition)Tj
5.3518 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(major)Tj
2.6078 0 Td
(con-)Tj
-35.1493 -1.2983 Td
(cern)Tj
1.9842 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(management)Tj
5.4368 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.846 0 Td
(patients)Tj
3.3675 0 Td
(receiving)Tj
3.8608 0 Td
(anti-neoplastic)Tj
6.1455 0 Td
(therapies.)Tj
-25.9652 -1.2983 Td
(One)Tj
1.9388 0 Td
(way)Tj
1.7972 0 Td
(to)Tj
1.0261 0 Td
(remedy)Tj
3.2372 0 Td
(malnutrition)Tj
5.3518 0 Td
(is)Tj
0.8503 0 Td
(through)Tj
3.447 0 Td
(the)Tj
1.4683 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(percutaneous)Tj
5.5786 0 Td
(endoscopic)Tj
4.7281 0 Td
(gastro-)Tj
-33.8227 -1.3039 Td
(stomy)Tj
2.6588 0 Td
(feeding)Tj
3.1635 0 Td
(tube)Tj
1.9785 0 Td
(\(PEG)Tj
2.4038 0 Td
(tube\).)Tj
2.5398 0 Td
(PEG)Tj
2.0636 0 Td
(tubes)Tj
2.3414 0 Td
(are)Tj
1.4457 0 Td
(inserted)Tj
3.4412 0 Td
(into)Tj
1.8426 0 Td
(the)Tj
1.4683 0 Td
(stomach,)Tj
3.8154 0 Td
(usually)Tj
3.016 0 Td
(through)Tj
-32.1786 -1.2982 Td
(abdominal)Tj
4.507 0 Td
(wall,)Tj
2.0579 0 Td
(and)Tj
1.7292 0 Td
(are)Tj
1.4513 0 Td
(used)Tj
2.0579 0 Td
(to)Tj
1.0262 0 Td
(provide)Tj
3.2881 0 Td
(enteral)Tj
2.9651 0 Td
(nutrition)Tj
3.8551 0 Td
(to)Tj
1.0261 0 Td
(patients)Tj
3.3675 0 Td
(in)Tj
1.0375 0 Td
(which)Tj
2.6475 0 Td
(the)Tj
1.4684 0 Td
(oral)Tj
1.7801 0 Td
(cavity)Tj
-34.2649 -1.2983 Td
(must)Tj
2.228 0 Td
(be)Tj
1.1452 0 Td
(bypassed)Tj
3.8097 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
1.5987 0 Td
(While)Tj
2.6532 0 Td
(previous)Tj
3.6454 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.0636 0 Td
(shown)Tj
2.8459 0 Td
(a)Tj
0.652 0 Td
(a)Tj
0.6576 0 Td
(positive)Tj
3.3166 0 Td
(correlation)Tj
4.6147 0 Td
(between)Tj
-32.2183 -1.3039 Td
(nutritional)Tj
4.5354 0 Td
(stasis)Tj
2.3017 0 Td
(and)Tj
1.7291 0 Td
(overall)Tj
2.9027 0 Td
(QoL,)Tj
2.2393 0 Td
(the)Tj
1.4683 0 Td
(relationship)Tj
4.989 0 Td
(between)Tj
3.5263 0 Td
(PEG)Tj
2.0636 0 Td
(tube)Tj
1.9785 0 Td
(use,)Tj
1.7575 0 Td
(nutrition)Tj
3.8551 0 Td
(status,)Tj
2.7213 0 Td
(and)Tj
-36.0678 -1.2983 Td
(treatment)Tj
4.1328 0 Td
(outcomes)Tj
4.0876 0 Td
(in)Tj
1.0374 0 Td
(patients)Tj
3.3676 0 Td
(who)Tj
1.9389 0 Td
(are)Tj
1.4513 0 Td
(undergoing)Tj
4.8699 0 Td
(anti-neoplastic)Tj
6.1455 0 Td
(therapies)Tj
3.8437 0 Td
(has)Tj
1.5421 0 Td
(not)Tj
1.576 0 Td
(been)Tj
-33.9928 -1.2982 Td
(thoroughly)Tj
4.6544 0 Td
(examined)Tj
4.1272 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
-7.5854 -1.2983 Td
(The)Tj
1.7858 0 Td
(goal)Tj
1.8708 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6725 0 Td
(retrospective)Tj
5.3631 0 Td
(matched)Tj
3.6737 0 Td
(cohort)Tj
2.8573 0 Td
(study)Tj
2.3867 0 Td
(is)Tj
0.8504 0 Td
(to)Tj
1.0261 0 Td
(evaluate)Tj
3.4583 0 Td
(if)Tj
0.7767 0 Td
(PEG)Tj
2.0636 0 Td
(tube)Tj
1.9786 0 Td
(placement)Tj
-31.9746 -1.3039 Td
(improved)Tj
4.1045 0 Td
(nutritional)Tj
4.5354 0 Td
(status)Tj
2.5001 0 Td
(and)Tj
1.7292 0 Td
(overall)Tj
2.9083 0 Td
(survival)Tj
3.3335 0 Td
(\(OS\))Tj
2.1203 0 Td
(in)Tj
1.0375 0 Td
(advanced)Tj
3.9968 0 Td
(GE)Tj
1.5024 0 Td
(cancer)Tj
2.8459 0 Td
(patients)Tj
3.3676 0 Td
(who)Tj
1.9389 0 Td
(are)Tj
-35.9204 -1.2983 Td
(undergoing)Tj
4.8698 0 Td
(anti-neoplastic)Tj
6.1455 0 Td
(therapy.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 278.3055 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F0 1 Tf
-6.4961 -1.5023 Td
(Ethics)Tj
2.9149 0 Td
(statement)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 243.3259 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(study)Tj
2.3924 0 Td
(was)Tj
1.6951 0 Td
(conducted)Tj
4.4277 0 Td
(based)Tj
2.4775 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(ethical)Tj
2.8403 0 Td
(standards)Tj
4.0819 0 Td
(prescribed)Tj
4.4163 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4684 0 Td
(Helsinki)Tj
3.5999 0 Td
(Declara-)Tj
-33.1027 -1.3039 Td
(tion)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(World)Tj
2.8346 0 Td
(Medical)Tj
3.4356 0 Td
(Association)Tj
4.8812 0 Td
(and)Tj
1.7291 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4684 0 Td
(approval)Tj
3.702 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(Western)Tj
3.6113 0 Td
(Institutional)Tj
-30.4722 -1.2982 Td
(Review)Tj
3.0954 0 Td
(Board)Tj
2.6362 0 Td
(\(WIRB\))Tj
3.4072 0 Td
(study)Tj
2.3924 0 Td
(#20140710.)Tj
4.7225 0 Td
(As)Tj
1.2699 0 Td
(this)Tj
1.6724 0 Td
(was)Tj
1.7008 0 Td
(a)Tj
0.652 0 Td
(retrospective)Tj
5.3574 0 Td
(study)Tj
2.3925 0 Td
(of)Tj
1.0148 0 Td
(existing)Tj
3.3165 0 Td
(data,)Tj
2.1373 0 Td
(the)Tj
-35.7673 -1.2983 Td
(requirement)Tj
5.1987 0 Td
(for)Tj
1.3889 0 Td
(patient)Tj
3.0047 0 Td
(consent)Tj
3.3336 0 Td
(was)Tj
1.6951 0 Td
(waived)Tj
3.016 0 Td
(by)Tj
1.1792 0 Td
(WIRB)Tj
2.7269 0 Td
(and)Tj
1.7291 0 Td
(consent)Tj
3.3336 0 Td
(was)Tj
1.6951 0 Td
(not)Tj
1.576 0 Td
(obtained)Tj
3.7304 0 Td
(for)Tj
1.389 0 Td
(this)Tj
-34.9963 -1.3039 Td
(study.)Tj
2.6135 0 Td
(Clinical)Tj
3.3165 0 Td
(information)Tj
5.074 0 Td
(was)Tj
1.7008 0 Td
(collected,)Tj
3.9628 0 Td
(and)Tj
1.7348 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(de-identified)Tj
5.3631 0 Td
(by)Tj
1.1792 0 Td
(removing)Tj
4.0762 0 Td
(all)Tj
-34.5087 -1.2983 Td
(identifiers)Tj
4.2632 0 Td
(that)Tj
1.7745 0 Td
(could)Tj
2.4548 0 Td
(be)Tj
1.1509 0 Td
(linked)Tj
2.7269 0 Td
(back)Tj
2.0806 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(patient.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 151.9937 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Study)Tj
2.7543 0 Td
(design)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 134.9858 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(We)Tj
1.6043 0 Td
(identified)Tj
4.0536 0 Td
(GE)Tj
1.5023 0 Td
(cancer)Tj
2.8346 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9899 0 Td
(metastatic)Tj
4.2746 0 Td
(disease)Tj
3.0104 0 Td
(that)Tj
1.7745 0 Td
(received)Tj
3.5319 0 Td
(oncology)Tj
3.8721 0 Td
(care)Tj
1.8709 0 Td
(at)Tj
0.9467 0 Td
(a)Tj
0.652 0 Td
(single)Tj
-35.2854 -1.2982 Td
(comprehensive)Tj
6.2872 0 Td
(cancer)Tj
2.8459 0 Td
(center)Tj
2.7099 0 Td
(and)Tj
1.7291 0 Td
(were)Tj
2.1203 0 Td
(evaluated)Tj
3.9912 0 Td
(by)Tj
1.1792 0 Td
(a)Tj
0.6576 0 Td
(nutritionist,)Tj
5.006 0 Td
(between)Tj
3.5263 0 Td
(December)Tj
4.3483 0 Td
(2008)Tj
-34.401 -1.2983 Td
(to)Tj
1.0261 0 Td
(February)Tj
3.8324 0 Td
(2014)Tj
2.126 0 Td
(and)Tj
1.7291 0 Td
(had)Tj
1.7121 0 Td
(at)Tj
0.9524 0 Td
(least)Tj
1.9786 0 Td
(2)Tj
0.6973 0 Td
(nutritionist)Tj
4.7792 0 Td
(follow-up)Tj
4.0932 0 Td
(visits.)Tj
2.4548 0 Td
(The)Tj
1.7858 0 Td
(first)Tj
1.8028 0 Td
(follow-up)Tj
4.0932 0 Td
(visit)Tj
1.8709 0 Td
(was)Tj
-34.9339 -1.3039 Td
(between)Tj
3.5262 0 Td
(46)Tj
1.6895 0 Td
(weeks)Tj
2.6078 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4741 0 Td
(second)Tj
3.0103 0 Td
(visit)Tj
1.8652 0 Td
(was)Tj
1.7008 0 Td
(approximately)Tj
5.9754 0 Td
(at)Tj
0.9524 0 Td
(12)Tj
1.1736 0 Td
(weeks)Tj
2.6078 0 Td
(from)Tj
2.2054 0 Td
(the)Tj
1.4683 0 Td
(initial)Tj
2.5455 0 Td
(nutri-)Tj
-34.5314 -1.2983 Td
(tion)Tj
1.8425 0 Td
(assessment.)Tj
4.8358 0 Td
(Patients)Tj
3.4073 0 Td
(with)Tj
1.9955 0 Td
(PEG)Tj
2.0636 0 Td
(tube)Tj
1.9786 0 Td
(were)Tj
2.1203 0 Td
(matched)Tj
3.6794 0 Td
(by)Tj
1.1792 0 Td
(histology)Tj
3.8551 0 Td
(type,)Tj
2.1373 0 Td
(similar)Tj
2.9877 0 Td
(age)Tj
1.542 0 Td
(range)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 199.559 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PEG)Tj
2.3102 0 Td
(tube)Tj
2.1331 0 Td
(effects)Tj
3.1252 0 Td
(on)Tj
1.311 0 Td
(nutritional)Tj
4.4646 0 Td
(status)Tj
2.8489 0 Td
(and)Tj
1.8567 0 Td
(survival)Tj
3.5433 0 Td
(in)Tj
0.978 0 Td
(advanced)Tj
4.4788 0 Td
(GE)Tj
1.6512 0 Td
(cancer)Tj
3.1748 0 Td
(patients)Tj
3.6567 0 Td
(getting)Tj
3.1607 0 Td
(anti-cancer)Tj
5.0811 0 Td
(therapy)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01886)Tj
4.089 0 Td
(28)Tj
0 g
2.0906 0 Td
(November)Tj
4.7622 0 Td
(29,)Tj
1.5875 0 Td
(2017)Tj
33.1018 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(8)Tj
/F9 1 Tf
-0.025 Tc
-66.9477 84.0904 Td
(Blend)Tj
2.3031 0 Td
(Therapeutics,)Tj
5.2016 0 Td
(Pharmatech,)Tj
4.9182 0 Td
(Amgen,)Tj
3.0969 0 Td
(Pfizer,)Tj
-15.5198 -1.3748 Td
(IDEA)Tj
2.0622 0 Td
(Pharma,)Tj
3.3449 0 Td
(Ignyta,)Tj
2.7496 0 Td
(Circulog)Tj
3.0544 0 Td
(ene)Tj
1.5378 0 Td
(Theranosti)Tj
3.9118 0 Td
(cs,)Tj
1.2898 0 Td
(AZ)Tj
-17.9505 -1.3749 Td
(Medical)Tj
3.0968 0 Td
(Board,)Tj
2.6434 0 Td
(GLG)Tj
1.8708 0 Td
(Council)Tj
2.9764 0 Td
(all)Tj
1.0276 0 Td
(outside)Tj
2.9268 0 Td
(this)Tj
1.5662 0 Td
(work;)Tj
-16.108 -1.3748 Td
(has)Tj
1.5378 0 Td
(received)Tj
3.3023 0 Td
(travel)Tj
2.2394 0 Td
(reimburse)Tj
3.7701 0 Td
(ment)Tj
2.126 0 Td
(from)Tj
-12.9756 -1.3748 Td
(NantWorks,)Tj
4.6134 0 Td
(Cambridge)Tj
4.2591 0 Td
(Healthtech)Tj
4.1457 0 Td
(Institute,)Tj
-13.0182 -1.3748 Td
(Tesaro;)Tj
2.9622 0 Td
(has)Tj
1.5378 0 Td
(an)Tj
1.1126 0 Td
(ownership)Tj
4.0961 0 Td
(interest)Tj
2.9693 0 Td
(in)Tj
0.8858 0 Td
(Circulogen)Tj
3.9544 0 Td
(e)Tj
-17.5182 -1.3748 Td
(Theranosti)Tj
3.9118 0 Td
(cs,)Tj
1.2898 0 Td
(and)Tj
1.5874 0 Td
(has)Tj
1.5378 0 Td
(a)Tj
0.6378 0 Td
(patent)Tj
2.5228 0 Td
(for)Tj
1.2544 0 Td
(methods)Tj
3.4937 0 Td
(and)Tj
-16.2355 -1.3748 Td
(kits)Tj
1.5094 0 Td
(to)Tj
0.9496 0 Td
(predict)Tj
2.7638 0 Td
(prognostic)Tj
4.1882 0 Td
(and)Tj
1.5875 0 Td
(therapeutic)Tj
4.337 0 Td
(outcome)Tj
-15.3355 -1.3748 Td
(in)Tj
0.8858 0 Td
(small)Tj
2.2039 0 Td
(cell)Tj
1.4457 0 Td
(lung)Tj
1.8355 0 Td
(cancer)Tj
2.6858 0 Td
(issued,)Tj
2.8489 0 Td
(outside)Tj
2.9338 0 Td
(the)Tj
-14.8394 -1.3748 Td
(submitted)Tj
3.9401 0 Td
(work.)Tj
2.289 0 Td
(No)Tj
1.2756 0 Td
(other)Tj
2.1544 0 Td
(author)Tj
2.622 0 Td
(has)Tj
1.5379 0 Td
(any)Tj
-13.819 -1.3749 Td
(competing)Tj
4.1598 0 Td
(interests)Tj
3.3875 0 Td
(to)Tj
0.9496 0 Td
(declare.)Tj
3.1039 0 Td
(Regarding)Tj
4.0465 0 Td
(the)Tj
-15.6473 -1.3748 Td
(patent:)Tj
2.7425 0 Td
(This)Tj
1.7858 0 Td
(does)Tj
2.0056 0 Td
(not)Tj
1.4244 0 Td
(alter)Tj
1.8213 0 Td
(our)Tj
1.474 0 Td
(adherenc)Tj
3.4087 0 Td
(e)Tj
0.6449 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
-16.2568 -1.3748 Td
(ONE)Tj
1.8708 0 Td
(policies)Tj
3.0048 0 Td
(on)Tj
1.1693 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
1.7929 0 Td
(and)Tj
ET
endstream
endobj
25 0 obj
<>stream
endstream
endobj
26 0 obj
<>stream
endstream
endobj
27 0 obj
<>stream
endstream
endobj
28 0 obj
<>stream
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
BT
12.4087 67.5926 Td
(materials.)Tj
ET
Q
endstream
endobj
37 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 10 0 R/Annots 40 0 R/Contents 41 0 R/TrimBox[0 0 612 792]>>
endobj
39 0 obj
<>stream
xwnGU>PAD*bЛ =`BIDj|1B iF:H5!$"]z(r>=望xϼ{ϞY̚}Y(
B(
B(
B(
B(
B(
B(
B(
B(
B(
B(
B(
B(
B(
BGWSN9哟>-oy˛棎:;?|G>"g?O;ηo=x櫓'pI'_LW(
B(
B(
Bؕg}1ynv}w}ҕt+_*Wկ~u{7Mnq[=~!r衇vaO(
BRa{w,}]:魋7
Jcq:@k!P@!P@!P:|;_}ߕWr'tI>O=/_җ$9?S@!P&Fa~xxviw~?=B ~P[WUF~_?o$:Gpjsw41q:@k!P@!P@!P"f7Y^c=^Ww%-@!P@!P+_w=/эnT8ʤB(
B(
B(
E`E?6T@!P@!P$b7sqǍ*g:Y@!P@!P@!k Hq>V@!P@!Pl-v WmRѢiVKB(
B(
B(
B`/Rg}7,ڇB(
B`3#0m@Ɂ=V-Cǹg_јwVg
B(
B(
B(
-oVs=m殟g^P525C0f\u)$1^ϴ3=m<g5&^~WBӝ\Zڲ.ݙd;d̍6L/dzQQ˟hr&sFᓗړKf[/[%ol[6C7]/{,
E ȋKoy;)я~E8u8L!P@!P@!P@!qys-'?ɏcRX~n?1Aq6S1sսq"W;0tr5ɻ֒Xn-]:o\K[Ҍ,|,mo\UxcĒƪKړyc$blsoܘeb1g9'qG -͘ϖ.?I_t9ȊF̝7MY*'\BXwB
9l`4gk?>:>}ծ}kS_B(
B(
B(vyVqk[(W6gK
,
B(v D!Pd\NO<xwqg#[[_B(
B(
B(
] ~Mg<{?A=}٢+0s~UHMw6d:rvvҺ|]{Τץ [HXefyu}-٠ҢgW]_ۢOh-C`yגt]Ş;8bWwAO~C:εuqvNT-@!P@!P@!P:{qtB(
B(
B`yBYiv!s1SvVg
B(
B(
B(
-oq\?@!P@!PlQR!HwC= G]:NQ}-
B(
B(
BصXFyK_pc:S@!P@!PL"0g?{Snq~sd!P@!P@!P@!q~[em!P@!PB`^ϧ=i\jW;ꨣJTW@!P@!P@!Pl48/{lF_F#iK]PM( ^=Mҵuҙ-}o @?ZBtO_3/&vPaي[Gr(EÊ'%]]3]ԊE@ z3_}.߄+,/_qtN7G`q-@_@!P@!P@!PL"0!br2LbCgW7\kD ;I?D^Z{"˔0b.Ώ$gm^;3*'ϜU=]UM<>]ĥ33YcT^4&c<#7dԍ;VQZܛ%wШY"zU9VV@!P@!P@!PkA ?[xŏ.AhW}fҘUV7k = TWSڢtyOhDi|]-yZ;@8>vaU+í@!P@!P@!P2LZK8sP]2B`s"Coyo5܍k3 hdh/e״'7"y$V,?v*[&҄72h|dXEf,YxeUXNW9k4cn71tU?}#yw^ |{k!P@!P@!P@! 0ǹm۶x-P;Zfs:YlNvo8Vruvsb~XmDs%MJQ݊Y1gd&,?Un߈/_憚G'љd8]-0KhJi@M8?O<)gWjK!P@!P@!PL2~G:ΑGXcϨwϹuq:dk!P@!P@!PIBDǙ<&M^\KBJbYsץ],~w~`a59]
gB!>b'8fr| &H$'pêKվ.BF!q9'-sQEuhh Qźy
ؤc_??\q_
|T@!P@!P@!P
>uڿc;cw~3lS]Au|[??oy[7wq_ۮQưzOq/zыw|s3ֺWK~
ƦQ4/#1uQ1}59||ӛWoн;':r͉'x '=yOLΣ?i&d)lLu-3p
g^?G7V&ۿz#Jl=cH|Cf5N);c:uqlOLӻHD\˿6`{\_VG!Q-o_
ox{9y?qzdq{<{/yC@e^&[iwJ)8\=$}S2IcQQC ~31Ao~}
>ORlcmis{r28'?`8[B(
B(
B(
!0Z}84{y\/cڶkQ҅A jnt`'EVnu[]b'`O:餱 2N'2C@Л=9ΑC,y/}TQ/